Welcome to LookChem.com Sign In|Join Free

CAS

  • or

10191-41-0

Post Buying Request

10191-41-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

10191-41-0 Usage

Chemical Properties

Different sources of media describe the Chemical Properties of 10191-41-0 differently. You can refer to the following data:
1. 1mg = 1.1 IU
2. Alpha tocopherol is a natural product. The PhEur 6.0 describes alpha-tocopherol as a clear, colorless or yellowish-brown, viscous, oily liquid.

Uses

Different sources of media describe the Uses of 10191-41-0 differently. You can refer to the following data:
1. dl-α-Tocopherol is the racemic analog of α-Tocopherol (T526125), the most bioactive of the naturally occurring forms of Vitamin E. Richest sources are green vegetables, grains, and oils, particularly palm, safflower and sunflower oils. dl-α-Tocopherol is an antioxidant that protects cell membrane lipids from oxidative damage.
2. DL-α-Tocopherol is used as an antioxidant that protects cell membrane lipids from oxidative damage.
3. These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.

Production Methods

Naturally occurring tocopherols are obtained by the extraction or molecular distillation of steam distillates of vegetable oils; for example, alpha tocopherol occurs in concentrations of 0.1–0.3% in corn, rapeseed, soybean, sunflower, and wheat germ oils.Beta and gamma tocopherol are usually found in natural sources along with alpha tocopherol. Racemic synthetic tocopherols may be prepared by the condensation of the appropriate methylated hydroquinone with racemic isophytol.

General Description

TGF-β3 (transforming growth factor-β3) belongs to the TGF β superfamily. The TGFβ3 gene is mapped to human chromosome 14q24.3

Flammability and Explosibility

Nonflammable

Pharmaceutical Applications

Alpha tocopherol is primarily recognized as a source of vitamin E, and the commercially available materials and specifications reflect this purpose. While alpha tocopherol also exhibits antioxidant properties, the beta, delta, and gamma tocopherols are considered to be more effective as antioxidants. Alpha-tocopherol is a highly lipophilic compound, and is an excellent solvent for many poorly soluble drugs.Of widespread regulatory acceptability, tocopherols are of value in oil- or fat-based pharmaceutical products and are normally used in the concentration range 0.001–0.05% v/v. There is frequently an optimum concentration; thus the autoxidation of linoleic acid and methyl linolenate is reduced at low concentrations of alpha tocopherol, and is accelerated by higher concentrations. Antioxidant effectiveness can be increased by the addition of oil-soluble synergists such as lecithin and ascorbyl palmitate. Alpha tocopherol may be used as an efficient plasticizer. It has been used in the development of deformable liposomes as topical formulations. d-Alpha-tocopherol has also been used as a non-ionic surfactant in oral and injectable formulations.

Biochem/physiol Actions

TGF-β3 (transforming growth factor-β3) regulates lymphocyte proliferation, apoptosis, hematopoiesis and embryogenesis to maintain immune homeostasis. TGF-β plays an important role in cell growth, differentiation, and survival. TGF-β3 specifically promotes chondrogenic differentiation.TGF-β3 is a strong growth inhibitor for normal and transformed epithelial, lymphoid, fibroblast, and keratinocyte cells. TGF-2 inhibits antitumor action of NK (natural killer) cells, T-cells, macrophages, monocytes and neutrophils. TGF-β3 is a tumor suppressor in the early stages of carcinogenesis, but in the later stages acts as a tumor promoter by inducing epithelial-mesenchymal transition and stimulating angiogenesis. TGF-β isoforms is known to participate in wound healing and tissue fibrosis. TGF-β3 is crucial for tissue restoration and scarless tissue repair. Mutation in the TGFβ3 gene is associated with development of non-syndromic cleft palate only (NS CPO), a rare congenital disease.

Safety

Tocopherols (vitamin E) occur in many food substances that are consumed as part of the normal diet. The daily nutritional requirement has not been clearly defined but is estimated to be 3.0–20.0 mg. Absorption from the gastrointestinal tract is dependent upon normal pancreatic function and the presence of bile. Tocopherols are widely distributed throughout the body, with some ingested tocopherol metabolized in the liver; excretion of metabolites is via the urine or bile. Individuals with vitamin E deficiency are usually treated by oral administration of tocopherols, although intramuscular and intravenous administration may sometimes be used. Tocopherols are well tolerated, although excessive oral intake may cause headache, fatigue, weakness, digestive disturbance, and nausea. Prolonged and intensive skin contact may lead to erythema and contact dermatitis. The use of tocopherols as antioxidants in pharmaceuticals and food products is unlikely to pose any hazard to human health since the daily intake from such uses is small compared with the intake of naturally occurring tocopherols in the diet. The WHO has set an acceptable daily intake of tocopherol used as an antioxidant at 0.15–2.0 mg/kg body-weight.

storage

Tocopherols are oxidized slowly by atmospheric oxygen and rapidly by ferric and silver salts. Oxidation products include tocopheroxide, tocopherylquinone, and tocopherylhydroquinone, as well as dimers and trimers. Tocopherol esters are more stable to oxidation than the free tocopherols but are in consequence less effective antioxidants. Tocopherols should be stored under an inert gas, in an airtight container in a cool, dry place and protected from light.

Purification Methods

Dissolve dl--tocopherol in anhydrous MeOH (15mL/g) cool to -6o for 1hour, then chill in a Dry-ice/acetone bath; crystallisation is induced by scratching with a glass rod. The dl--acetate [52225-20-4] (see DL-vitamin E actetate below) is a viscous yellow liquid with m -7o, b 184o/0.01mm, 224o/0.3mm, d 4 20 0.953, n D 20 1.496. It is used as a standard for Vitamin E activity where the unit of activity is attained with 1mg of pure dl--acetate. [Friedrich “Vitamins” Water de Guyter Publ, Berlin 1988, Beilstein 17/4 V 168.]

Incompatibilities

Tocopherols are incompatible with peroxides and metal ions, especially iron, copper, and silver. Tocopherols may be absorbed into plastic.

Regulatory Status

GRAS listed. Accepted in Europe as a food additive. Included in the FDA Inactive Ingredients Database (IV injections, powder, lyophilized powder for liposomal suspension; oral capsules, tablets, and topical preparations). Included in the Canadian List of Acceptable Non-medicinal Ingredients. Included in nonparenteral medicines licensed in the UK.

Check Digit Verification of cas no

The CAS Registry Mumber 10191-41-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,0,1,9 and 1 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 10191-41:
(7*1)+(6*0)+(5*1)+(4*9)+(3*1)+(2*4)+(1*1)=60
60 % 10 = 0
So 10191-41-0 is a valid CAS Registry Number.
InChI:InChI=1/C29H50O2/c1-20(2)12-9-13-21(3)14-10-15-22(4)16-11-18-29(8)19-17-26-25(7)27(30)23(5)24(6)28(26)31-29/h20-22,30H,9-19H2,1-8H3/t21-,22+,29+/m0/s1

10191-41-0 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (T0251)  DL-α-Tocopherol  >96.0%(GC)

  • 10191-41-0

  • 25g

  • 225.00CNY

  • Detail
  • TCI America

  • (T0251)  DL-α-Tocopherol  >96.0%(GC)

  • 10191-41-0

  • 250g

  • 910.00CNY

  • Detail
  • Alfa Aesar

  • (A17039)  DL-alpha-Tocopherol, 97+%   

  • 10191-41-0

  • 50g

  • 354.0CNY

  • Detail
  • Alfa Aesar

  • (A17039)  DL-alpha-Tocopherol, 97+%   

  • 10191-41-0

  • 250g

  • 1166.0CNY

  • Detail
  • Alfa Aesar

  • (A17039)  DL-alpha-Tocopherol, 97+%   

  • 10191-41-0

  • 1000g

  • 3957.0CNY

  • Detail
  • Sigma-Aldrich

  • (PHR1031)  AlphaTocopherol  pharmaceutical secondary standard; traceable to USP and PhEur

  • 10191-41-0

  • PHR1031-500MG

  • 732.19CNY

  • Detail
  • Sigma-Aldrich

  • (T1550000)  α-Tocopherol  European Pharmacopoeia (EP) Reference Standard

  • 10191-41-0

  • T1550000

  • 1,880.19CNY

  • Detail
  • Sigma-Aldrich

  • (90669)  (±)-α-Tocopherol  tested according to Ph.Eur.

  • 10191-41-0

  • 90669-50G-F

  • 1,222.65CNY

  • Detail
  • USP

  • (1667600)  AlphaTocopherol  United States Pharmacopeia (USP) Reference Standard

  • 10191-41-0

  • 1667600-250MG

  • 4,662.45CNY

  • Detail
  • Supelco

  • (47783)  (±)-α-Tocopherol  analytical standard

  • 10191-41-0

  • 000000000000047783

  • 286.65CNY

  • Detail
  • Cerilliant

  • (V-020)  (±)−α−Tocopherol (Vitamin E) solution  1.0 mg/mL in methanol, ampule of 1 mL, certified reference material

  • 10191-41-0

  • V-020-1ML

  • 760.50CNY

  • Detail
  • Sigma

  • (T3251)  (±)-α-Tocopherol  synthetic, ≥96% (HPLC)

  • 10191-41-0

  • T3251-5G

  • 156.78CNY

  • Detail

10191-41-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name Vitamin E

1.2 Other means of identification

Product number -
Other names DL-VITAMIN E

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only. Preservatives and Antioxidants
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:10191-41-0 SDS

10191-41-0Synthetic route

isophytol
505-32-8

isophytol

Trimethylhydroquinone
700-13-0

Trimethylhydroquinone

(+/-)-α-tocopherol
10191-41-0

(+/-)-α-tocopherol

Conditions
ConditionsYield
methanetrisulfonic acid In Ethylene carbonate; n-heptane; water at 50 - 140℃; for 1 - 1.66667h;92.4%
methanetrisulfonic acid In 1,2-propylene cyclic carbonate; n-heptane; water at 50 - 140℃; for 1h;91.2%
SnTf(51)-MCM-41 In hexane at 100℃; for 1h;
4-((3R,7R,11R)-3-Hydroxy-3,7,11,15-tetramethyl-hexadecyl)-5,7,8-trimethyl-1-oxa-spiro[2.5]octa-4,7-dien-6-one
129658-43-1

4-((3R,7R,11R)-3-Hydroxy-3,7,11,15-tetramethyl-hexadecyl)-5,7,8-trimethyl-1-oxa-spiro[2.5]octa-4,7-dien-6-one

(+/-)-α-tocopherol
10191-41-0

(+/-)-α-tocopherol

Conditions
ConditionsYield
With boron trifluoride diethyl etherate In diethyl ether for 4h;60%
5-nitromethyl-γ-tocopherol acetate

5-nitromethyl-γ-tocopherol acetate

(+/-)-α-tocopherol
10191-41-0

(+/-)-α-tocopherol

Conditions
ConditionsYield
With lithium aluminium tetrahydride; aluminium trichloride Reduction;17%
Trimethylhydroquinone
700-13-0

Trimethylhydroquinone

(+/-)-α-tocopherol
10191-41-0

(+/-)-α-tocopherol

(S)-2,3,4,6,7-Pentamethyl-2-((4S,8S)-4,8,12-trimethyl-tridecyl)-2,3-dihydro-benzofuran-5-ol

(S)-2,3,4,6,7-Pentamethyl-2-((4S,8S)-4,8,12-trimethyl-tridecyl)-2,3-dihydro-benzofuran-5-ol

Conditions
ConditionsYield
With 1-(bis-CF3SO2-methyl)-2,3,4,5,6-pentafluoro-benzene In carbon dioxide at 100℃; under 187515 Torr; for 16h; Product distribution; Further Variations:; Pressures; Catalysts; Solvents;A 79 % Chromat.
B 3.4 % Chromat.
DL-α-tocopherol acetate

DL-α-tocopherol acetate

(+/-)-α-tocopherol
10191-41-0

(+/-)-α-tocopherol

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 75 percent / nitric acid / acetic acid / 0.5 h / 20 °C
2: 17 percent / LiAlH4; AlCl3
View Scheme
Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 75 percent / silica gel / diethyl ether / 5 h / 0 - 5 °C
2: 60 percent / BF3*Et2O / diethyl ether / 4 h
View Scheme
α-tocopheroxyl radical

α-tocopheroxyl radical

(+/-)-α-tocopherol
10191-41-0

(+/-)-α-tocopherol

Conditions
ConditionsYield
With (E)-5-[2-4-(hydroxyphenyl)ethenyl]-1,3-benzenediol; sodium dodecyl-sulfate at 20℃; pH=7.4; Kinetics; Reagent/catalyst; aq. buffer; Micellar solution;
Trimethylhydroquinone
700-13-0

Trimethylhydroquinone

isophytol

isophytol

(+/-)-α-tocopherol
10191-41-0

(+/-)-α-tocopherol

Conditions
ConditionsYield
Stage #1: Trimethylhydroquinone With acid treated bentonite at 120 - 125℃; for 0.25h; Friedel-Crafts Alkylation;
Stage #2: isophytol at 120 - 125℃; for 10h; Catalytic behavior; Reagent/catalyst; Temperature; Friedel-Crafts Alkylation;
Stage #1: Trimethylhydroquinone With acid treated bentonite at 120 - 125℃; for 0.25h; Friedel-Crafts Alkylation;
Stage #2: isophytol at 120 - 125℃; for 10h; Catalytic behavior; Temperature; Reagent/catalyst; Friedel-Crafts Alkylation;
2,3,5-Trimethyl-1,4-benzoquinone
935-92-2

2,3,5-Trimethyl-1,4-benzoquinone

(+/-)-α-tocopherol
10191-41-0

(+/-)-α-tocopherol

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: palladium 10% on activated carbon; hydrogen / 23 h / 64 °C / 6000.6 Torr
2.1: acid treated bentonite / 0.25 h / 120 - 125 °C
2.2: 10 h / 120 - 125 °C
View Scheme
(+/-)-α-tocopherol
10191-41-0

(+/-)-α-tocopherol

epichlorohydrin
106-89-8

epichlorohydrin

2,5,7,8-tetramethyl-6-(oxiran-2-ylmethoxy)-2-(4,8,12-trimethyltridecyl)chroman
153821-44-4

2,5,7,8-tetramethyl-6-(oxiran-2-ylmethoxy)-2-(4,8,12-trimethyltridecyl)chroman

Conditions
ConditionsYield
With tetra(n-butyl)ammonium hydrogensulfate; potassium hydroxide In water at 0 - 20℃; for 4h;96%
(+/-)-α-tocopherol
10191-41-0

(+/-)-α-tocopherol

epichlorohydrin
106-89-8

epichlorohydrin

C32H54O3

C32H54O3

Conditions
ConditionsYield
With tetra(n-butyl)ammonium hydrogensulfate; potassium hydroxide In water at 0 - 20℃; for 4h;96%
(+/-)-α-tocopherol
10191-41-0

(+/-)-α-tocopherol

bromoacetic acid methyl ester
96-32-2

bromoacetic acid methyl ester

methyl 2-(2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)chroman-6-yloxy)acetate
1445229-61-7

methyl 2-(2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)chroman-6-yloxy)acetate

Conditions
ConditionsYield
Stage #1: (+/-)-α-tocopherol With sodium hydride In N,N-dimethyl-formamide at 20℃; for 0.5h;
Stage #2: bromoacetic acid methyl ester In N,N-dimethyl-formamide at 20℃; for 15h;
93%
trans-styrylacetic acid
2243-53-0, 59744-46-6, 1914-58-5

trans-styrylacetic acid

(+/-)-α-tocopherol
10191-41-0

(+/-)-α-tocopherol

(E)-(-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)chroman-6-yl) 4-phenyl-but-3-enoate

(E)-(-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)chroman-6-yl) 4-phenyl-but-3-enoate

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 24h;92%
α-L-polyglutamic acid

α-L-polyglutamic acid

(+/-)-α-tocopherol
10191-41-0

(+/-)-α-tocopherol

polyglutamate

polyglutamate

Conditions
ConditionsYield
Stage #1: α-L-polyglutamic acid; (+/-)-α-tocopherol With dmap; diisopropyl-carbodiimide In N,N-dimethyl-formamide at 15℃; for 3h;
Stage #2: With hydrogenchloride In water; N,N-dimethyl-formamide pH=2;
90%
(+/-)-α-tocopherol
10191-41-0

(+/-)-α-tocopherol

allyl bromide
106-95-6

allyl bromide

DL-α-tocopherol allyl ether

DL-α-tocopherol allyl ether

Conditions
ConditionsYield
With potassium carbonate In acetone for 10h; Reflux;90%
2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-heptadecaoxadopentacontan-52-oic acid

2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-heptadecaoxadopentacontan-52-oic acid

(+/-)-α-tocopherol
10191-41-0

(+/-)-α-tocopherol

C64H118O20

C64H118O20

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 40℃; for 10h; Solvent; Temperature;88%
trans-4-[({[(1,1-dimethylethyl)oxy]carbonyl}amino)methyl]cyclohexanecarboxylic acid

trans-4-[({[(1,1-dimethylethyl)oxy]carbonyl}amino)methyl]cyclohexanecarboxylic acid

(+/-)-α-tocopherol
10191-41-0

(+/-)-α-tocopherol

dl-α-tocopherol BOC-tranexamate

dl-α-tocopherol BOC-tranexamate

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide In pyridine at 20℃; for 24h;85%
(+/-)-α-tocopherol
10191-41-0

(+/-)-α-tocopherol

bromoacetic acid methyl ester
96-32-2

bromoacetic acid methyl ester

2-tocopheryloxy ethanol

2-tocopheryloxy ethanol

Conditions
ConditionsYield
Stage #1: (+/-)-α-tocopherol; bromoacetic acid methyl ester With potassium carbonate; potassium iodide In acetone Inert atmosphere; Reflux;
Stage #2: With lithium aluminium tetrahydride In tetrahydrofuran at 20℃; for 4h; Inert atmosphere;
85%
(+/-)-α-tocopherol
10191-41-0

(+/-)-α-tocopherol

bromoacetic acid methyl ester
96-32-2

bromoacetic acid methyl ester

serinol
534-03-2

serinol

C34H59NO5

C34H59NO5

Conditions
ConditionsYield
Stage #1: (+/-)-α-tocopherol; bromoacetic acid methyl ester With potassium carbonate; potassium iodide In acetone Inert atmosphere; Reflux;
Stage #2: serinol In dimethyl sulfoxide at 25℃; for 6h; Inert atmosphere;
85%
5-azidolevulinic acid
440359-99-9

5-azidolevulinic acid

(+/-)-α-tocopherol
10191-41-0

(+/-)-α-tocopherol

(+/-)-α-tocopherol-5-azidolevulinic acid ester

(+/-)-α-tocopherol-5-azidolevulinic acid ester

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 12h; Inert atmosphere;83%
(+/-)-α-tocopherol
10191-41-0

(+/-)-α-tocopherol

methyl iodide
74-88-4

methyl iodide

α-tocopheryl methyl ether

α-tocopheryl methyl ether

Conditions
ConditionsYield
With potassium carbonate In acetone for 36h; Methylation; Heating;82%
(+/-)-α-tocopherol
10191-41-0

(+/-)-α-tocopherol

5-((tert-butoxycarbonyl)amino)-4-oxopentanoic acid
72072-06-1

5-((tert-butoxycarbonyl)amino)-4-oxopentanoic acid

(+/-)-α-tocopherol-Boc-ALA ester

(+/-)-α-tocopherol-Boc-ALA ester

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 12h; Inert atmosphere;78%
4-(bromomethyl)-1-methyl-2,6,7-trioxabicyclo[2.2.2]-octane
60028-14-0

4-(bromomethyl)-1-methyl-2,6,7-trioxabicyclo[2.2.2]-octane

(+/-)-α-tocopherol
10191-41-0

(+/-)-α-tocopherol

C34H60O5

C34H60O5

Conditions
ConditionsYield
Stage #1: (+/-)-α-tocopherol With sodium hydride In N,N-dimethyl-formamide at 20℃; for 0.25h;
Stage #2: 4-(bromomethyl)-1-methyl-2,6,7-trioxabicyclo[2.2.2]-octane In tetrahydrofuran at 100℃; for 24h; Inert atmosphere;
Stage #3: With hydrogenchloride In methanol; dichloromethane at 50℃; for 4h; Inert atmosphere;
78%
methanol
67-56-1

methanol

(+/-)-α-tocopherol
10191-41-0

(+/-)-α-tocopherol

8a-methoxy-α-tocopherone
3329-05-3, 119616-52-3, 119616-53-4

8a-methoxy-α-tocopherone

Conditions
ConditionsYield
With potassium hydroxide; iodine at 10℃; for 0.166667h;68%
BOC-glycine
4530-20-5

BOC-glycine

(+/-)-α-tocopherol
10191-41-0

(+/-)-α-tocopherol

tert-Butoxycarbonylamino-acetic acid (R)-2,5,7,8-tetramethyl-2-((4R,8R)-4,8,12-trimethyl-tridecyl)-chroman-6-yl ester

tert-Butoxycarbonylamino-acetic acid (R)-2,5,7,8-tetramethyl-2-((4R,8R)-4,8,12-trimethyl-tridecyl)-chroman-6-yl ester

Conditions
ConditionsYield
Stage #1: BOC-glycine; (+/-)-α-tocopherol With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃;
Stage #2: In dichloromethane at -20℃; for 2h;
60%
With dicyclohexyl-carbodiimide In pyridine for 24h; Ambient temperature;
(+/-)-α-tocopherol
10191-41-0

(+/-)-α-tocopherol

5-fluorouracil-1-acetic acid
56059-30-4

5-fluorouracil-1-acetic acid

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide In tetrahydrofuran at 50℃; for 48h; Inert atmosphere;60%
(+/-)-α-tocopherol
10191-41-0

(+/-)-α-tocopherol

ethyl bromoacetate
105-36-2

ethyl bromoacetate

ethyl 2-tocopheryloxy acetate

ethyl 2-tocopheryloxy acetate

Conditions
ConditionsYield
Stage #1: (+/-)-α-tocopherol With sodium hydride In N,N-dimethyl-formamide at 0℃; for 0.25h; Inert atmosphere;
Stage #2: ethyl bromoacetate In N,N-dimethyl-formamide at 20℃; for 16h; Inert atmosphere;
60%
2-Iodobenzyl bromide
40400-13-3

2-Iodobenzyl bromide

(+/-)-α-tocopherol
10191-41-0

(+/-)-α-tocopherol

6-((2-iodobenzyl)oxy)-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)chromane

6-((2-iodobenzyl)oxy)-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)chromane

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 80℃; for 12h;38%
phthalic anhydride
85-44-9

phthalic anhydride

(+/-)-α-tocopherol
10191-41-0

(+/-)-α-tocopherol

mono-tocopherol phthalate
850655-12-8

mono-tocopherol phthalate

Conditions
ConditionsYield
With stannous octoate In N,N-dimethyl acetamide at 140℃; for 24h;31.1%
terephthalic acid
100-21-0

terephthalic acid

(+/-)-α-tocopherol
10191-41-0

(+/-)-α-tocopherol

mono-tocopherol terephthalate
850655-10-6

mono-tocopherol terephthalate

Conditions
ConditionsYield
With dmap; 2-chloro-1-methyl-pyridinium iodide In N,N-dimethyl acetamide at 50℃; for 4h;27.6%
C45H92N2O2

C45H92N2O2

(+/-)-α-tocopherol
10191-41-0

(+/-)-α-tocopherol

C74H140N2O3

C74H140N2O3

Conditions
ConditionsYield
With Medroxyprogesterone acetate; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃;26%
trimethoxysilane
2487-90-3

trimethoxysilane

(+/-)-α-tocopherol
10191-41-0

(+/-)-α-tocopherol

6-Bromo-1-hexene
2695-47-8

6-Bromo-1-hexene

(6-((DL-α-tocopheryl)oxy)hexyl)trimethoxysilane

(6-((DL-α-tocopheryl)oxy)hexyl)trimethoxysilane

Conditions
ConditionsYield
Stage #1: (+/-)-α-tocopherol; 6-Bromo-1-hexene With sodium hydroxide In N,N-dimethyl-formamide at 20℃; for 12h; Inert atmosphere; Schlenk technique;
Stage #2: trimethoxysilane With platinum(0)-1,3-divinyl-1,1,3,3-tetramethyldisiloxane complex In 5,5-dimethyl-1,3-cyclohexadiene; N,N-dimethyl-formamide at 50℃; for 12h; Inert atmosphere; Schlenk technique;
21%
(+/-)-α-tocopherol
10191-41-0

(+/-)-α-tocopherol

β-D-galactose peracetate
4163-60-4

β-D-galactose peracetate

α-tocopheryl 2,3,4,6-tetra-O-acetyl-β-D-galactopyranoside

α-tocopheryl 2,3,4,6-tetra-O-acetyl-β-D-galactopyranoside

Conditions
ConditionsYield
With toluene-4-sulfonic acid In nitrobenzene at 90℃; for 5h;20%
(+/-)-α-tocopherol
10191-41-0

(+/-)-α-tocopherol

β-D-glucose pentaacetate
604-69-3

β-D-glucose pentaacetate

all-rac-α-tocopheryl 2,3,4,6-tetra-O-acetyl-β-D-glucopyranoside
99502-55-3

all-rac-α-tocopheryl 2,3,4,6-tetra-O-acetyl-β-D-glucopyranoside

Conditions
ConditionsYield
With toluene-4-sulfonic acid In nitrobenzene at 90℃; for 5h;15%
linoleic acid
60-33-3

linoleic acid

(+/-)-α-tocopherol
10191-41-0

(+/-)-α-tocopherol

dl-α-Tocopheryl linoleate
36148-84-2, 51744-92-4, 146566-14-5

dl-α-Tocopheryl linoleate

Conditions
ConditionsYield
With 1,1'-carbonyldiimidazole In chloroform98.9 % Chromat.

10191-41-0Related news

Selenium and Vitamin E (cas 10191-41-0) Concentrations in a Healthy Donkey Population in Central Italy07/23/2019

Selenium and vitamin E protect the body against oxidative stress. Clinical manifestations of their deficiency in equids include neurologic and muscular symptoms. Despite the importance of donkeys as working and production animals, there is a dearth of scientific data on selenium and vitamin E no...detailed

10191-41-0Relevant articles and documents

New heterogeneous catalysts for greener routes in the synthesis of fine chemicals

Coman, Simona M.,Pop, Georgeta,Stere, Cristina,Parvulescu, Vasile I.,El Haskouri, Jamal,Beltrán, Daniel,Amorós, Pedro

, p. 388 - 399 (2007)

New strong Lewis acid SnTf-MCM-41 and SnTf-UVM-7 catalysts with unimodal and bimodal pore systems were prepared in a two-step synthesis in which the triflic acid (Tf) was incorporated to previously synthesized mesoporous tin-containing silicas. The Sn incorporation inside the pore walls was carried out through the Atrane method. The SnTf-UVM-7 catalysts were prepared by aggregating nanometric mesoporous particles defining a hierarchic textural-type additional pore system. Following these procedures, catalysts with different Si/Sn ratios-21.8 to 50.8 for SnTf-MCM-41 and 18.4 for SnTf-UVM-7-were prepared. These new materials were tested in the acylation of aromatic sulfonamides using acetic acid as the acylating agent and in the synthesis of (dl)-[α]-tocopherol through the condensation of 2,3,6-trimethylhydroquinone (TMHQ) with isophytol (IP). The activity data indicate that these heterogeneous catalysts are very active, corresponding to high yields in acylated compounds as 65.5% and very high selectivity to (dl)-[α]-tocopherol (94%, for a conversion of 98%).

Synthesis of (all-rac)-α-tocopherol in supercritical carbon dioxide: Tuning of the product selectivity in batch and continuous-flow reactors

Kokubo, Yoshiaki,Hasegawa, Aiko,Kuwata, Shigeki,Ishihara, Kazuaki,Yamamoto, Hisashi,Ikariya, Takao

, p. 220 - 224 (2005)

α-Tocopherol was synthesized using a condensation reaction of 2,3,6-trimethylhydroquinone with isophytol in supercritical CO2 using batch and continuous-flow reactors. In the batch reaction catalyzed by a fluorinated molecular catalyst bearing strong Bronsted acidity, C 6F5CHTf2 (Tf=SO2CF3), an increase in the CO2 pressure causes a marked increase in the product selectivity for α-tocopherol, albeit with a slight decrease in the product yield. The solubility measurements by extraction experiments and the supercritical fluid NMR (scNMR) indicate that the homogeneous and non-polar reaction phase in scCO2 is crucial to obtain α-tocopherol with high selectivity. A continuous flow scCO2 process for the condensation reaction can be performed with a strong acid resin, Amberlyst 15, as a solid acid catalyst to give the desired product with high selectivity.

SYNTHESIS OF CHROMANOL DERIVATIVES

-

, (2020/03/05)

The present invention relates to a process for the production of chromanol derivatives, more specifically to a process for preparing a compound of the general formula (I) wherein R1, R2 and R3 independently of each other are selected from hydrogen and methyl, R4 is selected from hydrogen and C1-C6-alkanoyl, and X is selected from C1-C20-alkyl and C2-C20-alkenyl.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 10191-41-0